These findings provide insights into mechanisms underlying castration resistance in prostate cancer and reveal a potential strategy to circumvent therapeutic resistance in patients with homozygous HSD3B1(1245C) inheritance (Figure 1). This evidence concerns the gene HSD3B1 and prostate cancer.